KMDA
Kamada Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$8.54
+3.26%Margins
Gross margin
40.8%
EBITDA margin
21.9%
EBIT margin
14.5%
Net margin
11.6%
FCF margin
13.8%
8.3%
Return on equity
5.8%
Return on assets
9.9%
Return on invested capital
0.50x
Asset turnover
$36.0M
Cash from operations
$1.22
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026